pyrene-1-aldehyde: RN given refers to cpd with aldehyde group in position 1 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 232848 |
| SCHEMBL ID | 52121 |
| MeSH ID | M0111065 |
| Synonym |
|---|
| BIDD:GT0484 |
| c17h10o |
| AKOS015840462 |
| 1-pyrene-carboxaldehyde |
| nsc30811 |
| 1-pyrenecarboxaldehyde |
| nsc-30811 |
| 3029-19-4 |
| 1-pyrene carboxaldehyde |
| 3-formylpyrene |
| einecs 221-196-6 |
| 1-pyrenealdehyde |
| 1-formylpyrene |
| nsc 30811 |
| ccris 3163 |
| 3-pyrenealdehyde |
| 3-pyrenecarboxaldehyde |
| pyrene-1-carbaldehyde |
| pyrene-1-aldehyde |
| 3-pyrenylaldehyde |
| 1-pyrenecarboxaldehyde, 99% |
| P1448 |
| pyrenecarboxaldehyde |
| unii-i9h95pvi1p |
| i9h95pvi1p , |
| FT-0608288 |
| STL377328 |
| SCHEMBL52121 |
| BBL027449 |
| pyrene-1-carboxaldehyde |
| pyrene carboxaldehyde |
| 1-pyrenecarbaldehyde |
| FD15013 |
| mfcd00004139 |
| DTXSID40184373 |
| J-017887 |
| 2,2-dimethyl-thiazolidine-4-carboxylicacid |
| AS-48903 |
| pyren-3-aldehyd |
| SY049928 |
| A876243 |
| CS-0138253 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (28.26) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||